Your browser doesn't support javascript.
loading
CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis.
Loreth, Desiree; Schuette, Moritz; Zinke, Jenny; Mohme, Malte; Piffko, Andras; Schneegans, Svenja; Stadler, Julia; Janning, Melanie; Loges, Sonja; Joosse, Simon A; Lamszus, Katrin; Westphal, Manfred; Müller, Volkmar; Glatzel, Markus; Matschke, Jakob; Gebhardt, Christoffer; Schneider, Stefan W; Belczacka, Iwona; Volkmer, Beate; Greinert, Rüdiger; Yaspo, Marie-Laure; Harter, Patrick N; Pantel, Klaus; Wikman, Harriet.
  • Loreth D; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Schuette M; Alacris Theranostics GmbH, Max-Planck-Straße 3, 12489 Berlin, Germany.
  • Zinke J; Institute of Neurology (Edinger Institute), Goethe University, 60528 Frankfurt am Main, Germany.
  • Mohme M; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, 60528 Frankfurt am Main, Germany.
  • Piffko A; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Schneegans S; Frankfurt Cancer Institute (FCI), 60528 Frankfurt am Main, Germany.
  • Stadler J; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Janning M; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Loges S; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Joosse SA; Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Lamszus K; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Westphal M; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
  • Müller V; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Glatzel M; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Matschke J; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, University of Heidelberg, 68167 Mannheim, Germany.
  • Gebhardt C; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Schneider SW; Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Belczacka I; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Volkmer B; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Greinert R; Department of Gynecology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Yaspo ML; Department of Neuropathology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Harter PN; Department of Neuropathology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Pantel K; Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Wikman H; Department of Dermatology and Venerology, University Hospital Hamburg-Eppendorf, 20246 Hamburg, Germany.
Int J Mol Sci ; 22(13)2021 Jun 29.
Article en En | MEDLINE | ID: mdl-34209696

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Antígenos de Diferenciación de Linfocitos B / Antígenos de Histocompatibilidad Clase II / Receptores de Hialuranos / Células Neoplásicas Circulantes Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Antígenos de Diferenciación de Linfocitos B / Antígenos de Histocompatibilidad Clase II / Receptores de Hialuranos / Células Neoplásicas Circulantes Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article